Chronic dizziness and anxiety: Effect of course of illness on treatment outcome

Jeffrey P Staab, Michael J. Ruckenstein

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: To investigate the hypothesis that the efficacy of selective serotonin reuptake inhibitors (SSRIs) for chronic subjective dizziness (CSD) and anxiety depends on the longitudinal pattern of the patients' symptoms. Design: Prospective cohort study. Setting: Tertiary care, multidisciplinary, balance center. Patients: Eighty-eight consecutive patients treated with an SSRI for CSD and anxiety between 1998 and 2003. All patients were referred for evaluation of unremitting dizziness. They entered SSRI treatment after comprehensive neurotologic and psychiatric evaluations revealed a syndrome of CSD with accompanying anxiety. Patients were separated into 3 groups according to their longitudinal patterns of illness: (1) otogenic, defined as primary neurotologic conditions triggering secondary anxiety disorders; (2) psychogenic, defined as anxiety disorders alone causing dizziness; and (3) interactive, defined neurotologic conditions exacerbating preexisting anxiety. Interventions: Patients with CSD were treated with an SSRI according to an established protocol for at least 8 weeks or until they proved intolerant to medication. Main Outcome Measures: Changes in dizziness and anxiety as measured by the Clinical Global Impressions-Improvement scale. Results: Patients with the otogenic and psychogenic patterns of illness had a more complete response to SSRI treatment than did patients in the interactive group (P<.01). Rates of SSRI intolerance were similar for all 3 groups. Conclusions: Selective serotonin reuptake inhibitors are effective for patients with CSD and anxiety. However, patients with clinically significant anxiety predating neurotologic illness may require more intensive interventions.

Original languageEnglish (US)
Pages (from-to)675-679
Number of pages5
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume131
Issue number8
DOIs
StatePublished - Aug 2005
Externally publishedYes

Fingerprint

Dizziness
Anxiety
Serotonin Uptake Inhibitors
Anxiety Disorders
Preexisting Condition Coverage
Tertiary Healthcare
Psychiatry
Cohort Studies
Outcome Assessment (Health Care)
Prospective Studies

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Chronic dizziness and anxiety : Effect of course of illness on treatment outcome. / Staab, Jeffrey P; Ruckenstein, Michael J.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 131, No. 8, 08.2005, p. 675-679.

Research output: Contribution to journalArticle

@article{0263ae7d1e574c22aad4356bf49a6133,
title = "Chronic dizziness and anxiety: Effect of course of illness on treatment outcome",
abstract = "Objective: To investigate the hypothesis that the efficacy of selective serotonin reuptake inhibitors (SSRIs) for chronic subjective dizziness (CSD) and anxiety depends on the longitudinal pattern of the patients' symptoms. Design: Prospective cohort study. Setting: Tertiary care, multidisciplinary, balance center. Patients: Eighty-eight consecutive patients treated with an SSRI for CSD and anxiety between 1998 and 2003. All patients were referred for evaluation of unremitting dizziness. They entered SSRI treatment after comprehensive neurotologic and psychiatric evaluations revealed a syndrome of CSD with accompanying anxiety. Patients were separated into 3 groups according to their longitudinal patterns of illness: (1) otogenic, defined as primary neurotologic conditions triggering secondary anxiety disorders; (2) psychogenic, defined as anxiety disorders alone causing dizziness; and (3) interactive, defined neurotologic conditions exacerbating preexisting anxiety. Interventions: Patients with CSD were treated with an SSRI according to an established protocol for at least 8 weeks or until they proved intolerant to medication. Main Outcome Measures: Changes in dizziness and anxiety as measured by the Clinical Global Impressions-Improvement scale. Results: Patients with the otogenic and psychogenic patterns of illness had a more complete response to SSRI treatment than did patients in the interactive group (P<.01). Rates of SSRI intolerance were similar for all 3 groups. Conclusions: Selective serotonin reuptake inhibitors are effective for patients with CSD and anxiety. However, patients with clinically significant anxiety predating neurotologic illness may require more intensive interventions.",
author = "Staab, {Jeffrey P} and Ruckenstein, {Michael J.}",
year = "2005",
month = "8",
doi = "10.1001/archotol.131.8.675",
language = "English (US)",
volume = "131",
pages = "675--679",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Chronic dizziness and anxiety

T2 - Effect of course of illness on treatment outcome

AU - Staab, Jeffrey P

AU - Ruckenstein, Michael J.

PY - 2005/8

Y1 - 2005/8

N2 - Objective: To investigate the hypothesis that the efficacy of selective serotonin reuptake inhibitors (SSRIs) for chronic subjective dizziness (CSD) and anxiety depends on the longitudinal pattern of the patients' symptoms. Design: Prospective cohort study. Setting: Tertiary care, multidisciplinary, balance center. Patients: Eighty-eight consecutive patients treated with an SSRI for CSD and anxiety between 1998 and 2003. All patients were referred for evaluation of unremitting dizziness. They entered SSRI treatment after comprehensive neurotologic and psychiatric evaluations revealed a syndrome of CSD with accompanying anxiety. Patients were separated into 3 groups according to their longitudinal patterns of illness: (1) otogenic, defined as primary neurotologic conditions triggering secondary anxiety disorders; (2) psychogenic, defined as anxiety disorders alone causing dizziness; and (3) interactive, defined neurotologic conditions exacerbating preexisting anxiety. Interventions: Patients with CSD were treated with an SSRI according to an established protocol for at least 8 weeks or until they proved intolerant to medication. Main Outcome Measures: Changes in dizziness and anxiety as measured by the Clinical Global Impressions-Improvement scale. Results: Patients with the otogenic and psychogenic patterns of illness had a more complete response to SSRI treatment than did patients in the interactive group (P<.01). Rates of SSRI intolerance were similar for all 3 groups. Conclusions: Selective serotonin reuptake inhibitors are effective for patients with CSD and anxiety. However, patients with clinically significant anxiety predating neurotologic illness may require more intensive interventions.

AB - Objective: To investigate the hypothesis that the efficacy of selective serotonin reuptake inhibitors (SSRIs) for chronic subjective dizziness (CSD) and anxiety depends on the longitudinal pattern of the patients' symptoms. Design: Prospective cohort study. Setting: Tertiary care, multidisciplinary, balance center. Patients: Eighty-eight consecutive patients treated with an SSRI for CSD and anxiety between 1998 and 2003. All patients were referred for evaluation of unremitting dizziness. They entered SSRI treatment after comprehensive neurotologic and psychiatric evaluations revealed a syndrome of CSD with accompanying anxiety. Patients were separated into 3 groups according to their longitudinal patterns of illness: (1) otogenic, defined as primary neurotologic conditions triggering secondary anxiety disorders; (2) psychogenic, defined as anxiety disorders alone causing dizziness; and (3) interactive, defined neurotologic conditions exacerbating preexisting anxiety. Interventions: Patients with CSD were treated with an SSRI according to an established protocol for at least 8 weeks or until they proved intolerant to medication. Main Outcome Measures: Changes in dizziness and anxiety as measured by the Clinical Global Impressions-Improvement scale. Results: Patients with the otogenic and psychogenic patterns of illness had a more complete response to SSRI treatment than did patients in the interactive group (P<.01). Rates of SSRI intolerance were similar for all 3 groups. Conclusions: Selective serotonin reuptake inhibitors are effective for patients with CSD and anxiety. However, patients with clinically significant anxiety predating neurotologic illness may require more intensive interventions.

UR - http://www.scopus.com/inward/record.url?scp=23944520814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944520814&partnerID=8YFLogxK

U2 - 10.1001/archotol.131.8.675

DO - 10.1001/archotol.131.8.675

M3 - Article

C2 - 16103297

AN - SCOPUS:23944520814

VL - 131

SP - 675

EP - 679

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 8

ER -